Developer docs
API playgroundTry for free, no card

Search company profiles

toll holdings ltd

Full company profile

uuid02m8b3s

Namestring
toll holdings ltd
Legal namestring
AFSED - Association Française des Syndromes d'Ehlers-Danlos
Websiteurl
afsed.com
Company typeenum
Private
Founded yearint
1997
Descriptiontext

AFSED (Association Française des Syndromes d'Ehlers-Danlos) is a French nonprofit patient association founded in February 1997 and governed under French Loi 1901 law, headquartered at 67 rue Jules Lecesne, 76600 Le Havre. It is the reference French patient organization for Ehlers-Danlos Syndromes (EDS), a group of rare genetic connective-tissue disorders. The association is led by President Marie-Noëlle Gaveau with a volunteer Board of Directors and a Scientific Council, and its primary constituencies are EDS patients, their families, and the medical professionals who treat them. AFSED does not operate technology products; its core functions are patient support, medical information dissemination, therapeutic education, and medical research funding for all EDS subtypes.

The organization's service portfolio includes a quarterly journal (SED l'INFO), monthly email newsletters, a HONcode-certified website (afsed.com), regional meetings, an annual medical day in Paris, and the PrEduSED therapeutic patient education program for hypermobility-type EDS delivered at Clinique des Massues in Lyon. AFSED distributes emergency cards for vascular EDS patients, European patient passports, technical information sheets, and school guides. It co-funds medical research via annual calls for proposals (e.g., 126,620 euros pledged in 2018) and participates in research cohorts including RaDiCo-SED vasculaire. The association is formally integrated into France's national rare-disease infrastructure through Alliance Maladies Rares, FAVA-Multi, Maladies Rares Info Service, and three national reference centers (HEGP, Hôpital Raymond Poincaré Garches, Hôpital Necker-Enfants-Malades), as well as European Reference Networks VASCern and ReCOnnet and EURORDIS.

AFSED's revenue model is a mix of individual membership dues (30 euros/year, plus an optional 5 euros for the journal), individual and corporate donations, fundraising events including Téléthon solidarity walks and GROUPAMA partnerships, and pass-through research grants. Strategic financial partners include Fondation ROCHE, GROUPAMA, AFLAR, and AFM-Téléthon. Distribution is direct to members and through regional events and partner networks, with no commercial resellers. The association holds HONcode certification, an Orphanet listing, and a 2015 Label du droit des patients award recognizing its patient-centered VIVAMARE application.

Short descriptiontext

AFSED is the French reference nonprofit patient association for Ehlers-Danlos Syndromes, founded 1997, supporting patients and families across France through information, therapeutic education, regional events, and medical research funding, in partnership with national reference centers and European Reference Networks.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLe Havre, France
HQ citystring
Le Havre
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease support, patient advocacy, therapeutic education, medical research funding, membership association
NAICS code2 codes
  • Services for the Elderly and Persons with Disabilities624120
  • Health Care and Social Assistance62
SIC code1 code
  • Services-Membership Organizations8600
Product category
Rare Disease Patient Association Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Membership fees
TypeSubscription Recurring
Description

Annual membership fees of 30 euros per year providing access to all association activities, manifestations, and publications including the journal SED l'INFO (with additional 5 euros for the journal)

afsed.com
2Donations and fundraising
TypeAffiliate Referral
Description

Donations from individuals and organizations; fundraising events including solidarity walks, charity sales, and participation in Téléthon

afsed.com
3Research project funding
TypeProfessional Services
Description

Funding for medical research projects up to 60,000 euros per project through annual calls for proposals

afsed.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Others, Personnel, Operations
Pricing details1 tier
1Standard membership - 30 euros/year
ModelSubscriptionBilling cadenceAnnual
Notes

30 euros per year with access to all manifestations and publications. Add 5 euros for the journal SED l'INFO.

afsed.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

AFSED is a French nonprofit patient association that supports individuals and families affected by Ehlers-Danlos Syndromes through membership services, therapeutic education programs (PrEduSED), annual medical days, a quarterly journal (SED l'INFO), emergency cards for vascular EDS patients, and a national helpline. The association funds medical research projects via annual calls for proposals and raises funds through memberships, donations, and solidarity events including Téléthon.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reduced diagnostic delay through medical professional training and awareness programs
+1 more record
Product and service8 records
1Annual Membership
CategoryMembership
Description

Annual membership open to patients, families, and supporters of the Association Française des Syndromes d'Ehlers-Danlos, providing access to all association activities, events, and publications for a fee of 30 euros per year (plus 5 euros for the quarterly journal).

2PrEduSED Therapeutic Education Program
CategoryTherapeutic Education
Description

Week-long therapeutic patient education (Education Thérapeutique du Patient) program at Clinique des Massues in Lyon, teaching hypermobility-type EDS patients to manage their disease, pain, and daily life through structured sessions held several times per year.

3Emergency Cards for Vascular EDS Patients
CategoryPatient Resource
Description

Urgency cards distributed to patients with vascular EDS, designed to inform emergency medical personnel of the patient's specific condition and care requirements to ensure appropriate emergency response.

4Quarterly Journal SED l'INFO
CategoryPatient Resource
Description

Quarterly journal providing medical articles, patient stories, association news, and research updates to AFSED members and subscribers.

5Annual Research Funding Calls for Projects
CategoryResearch Funding
Description

Annual calls for proposals funding medical research projects on Ehlers-Danlos Syndromes, with grants of up to 60,000 euros per project to support clinical and basic science research initiatives.

6Donations and Fundraising Campaigns
CategoryFundraising
Description

Donation and fundraising programs including solidarity walks (Randoraid de la Loire, GROUPAMA walks in Normandy and Pays de Loire), charity sales, and annual Téléthon participation to fund AFSED's operations and research.

7Patient Helpline and Reference Center Navigation
CategoryPatient Support Service
Description

Phone helpline (0820 20 37 33) and reference center navigation services connecting EDS patients and families with specialized care providers such as HEGP, Necker-Enfants-Malades, and Hôpital Raymond Poincaré.

8Annual Medical Day Conference
CategoryEducational Event
Description

Annual gathering in Paris bringing together patients, families, and medical professionals with expert presentations and workshops, typically held in November each year.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
1Alliance Maladies Rares (Rare Diseases Alliance)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

AFSED is a member of the Alliance Maladies Rares, which brings together rare disease organizations in France. This affiliation provides national visibility, policy advocacy, and connection to the broader rare disease community.

afsed.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

AFSED is affiliated with EURORDIS, the European organization bringing together rare disease associations across Europe. Enables participation in European policy initiatives and cross-border research.

3European Reference Network (ERN) VASCern
Strategic tierCoreTypeStrategic or Co-development Partner
Description

AFSED participates in VASCern, the European Reference Network for rare vascular diseases, connecting French reference centers with European centers of excellence for vascular EDS.

afsed.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

AFSED participates in ReCOnnet, the ERN for connective tissue and musculoskeletal disorders, supporting care for non-vascular EDS types.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

AFSED is part of FAVA-Multi, a filiere bringing together Reference Centers, competence centers and patient associations for rare vascular diseases, coordinating care pathways across France.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

AFSED directs patients to Maladies Rares Info Service (tel: 01.56.53.81.36) for general rare disease information, providing a national resource for patients and families.

7Centre de Référence des Maladies Vasculaires Rares (HEGP)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

National Reference Center for Rare Vascular Diseases at Hôpital Européen Georges Pompidou, Paris, directed by Pr Xavier Jeunemaitre. AFSED collaborates on research, patient support, and PNDS development for vascular EDS.

afsed.com
8Centre de référence des syndromes d'Ehlers-Danlos non vasculaires (Garches)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Reference center for non-vascular EDS at Hôpital Raymond Poincaré, Garches, under Dr Karelle Bénistan. Provides specialized care for classical and hypermobility EDS types.

afsed.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pediatric reference center under Pr Valérie Cormier-Daire for children with non-vascular EDS, part of the national care network.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

AFSED co-organizes symposia with AFM-Téléthon, such as the Interface Muscle-tissu conjonctif symposium held in Lyon in March 2016.

11Orphanet
Strategic tierMajorTypeStrategic or Co-development Partner
Description

AFSED is listed on Orphanet, the European portal for rare disease information, providing visibility and referral pathways for patients seeking specialized care.

afsed.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

US umbrella organization for rare disease patient associations. Comparable in mission and structure to AFSED's relationship with Alliance Maladies Rares, providing advocacy, research funding, and patient resources at national scale.

TypeBroad incumbent
Description

European umbrella organization for rare disease patient associations, of which AFSED is a member. Sets pan-European policy, runs Rare Disease Day, and coordinates patient advocacy across member associations including AFSED.

3Orphanet
TypeOthers
Description

European reference portal for rare diseases and orphan drugs, on which AFSED is listed. Acts as the directory and information backbone connecting EDS patient associations to clinicians and researchers worldwide.

TypeBroad incumbent
Description

Major French rare disease nonprofit running annual Téléthon fundraising and funding neuromuscular disease research. AFSED co-organizes symposia with AFM-Téléthon; comparable scale and French rare-disease nonprofit model.

TypeDirect peer
Description

Global patient organization for all EDS types, headquartered in the US, running international research, education, and the global EDS ECHO program. Directly comparable mission and scope to AFSED, but operating internationally rather than nationally.

TypeDirect peer
Description

UK-based membership charity for EDS patients and families, providing helpline, information resources, and funding research. Closest national-association peer to AFSED in terms of patient support, fundraising, and member services model.

7Alliance Maladies Rares
TypeBroad incumbent
Description

French national alliance of rare disease patient associations, of which AFSED is a member. Provides policy advocacy, training, and shared services to member organizations including AFSED.

8Deutsche Ehlers-Danlos Initiative e.V.
TypeRegional player
Description

German national EDS patient association providing member support, information, and local events. Directly comparable role to AFSED in a neighboring country with similar healthcare system structure.

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

toll holdings ltd

Rare Disease Patient Association Servicesafsed.com

AFSED is the French reference nonprofit patient association for Ehlers-Danlos Syndromes, founded 1997, supporting patients and families across France through information, therapeutic education, regional events, and medical research funding, in partnership with national reference centers and European Reference Networks.

What toll holdings ltd does

AFSED (Association Française des Syndromes d'Ehlers-Danlos) is a French nonprofit patient association founded in February 1997 and governed under French Loi 1901 law, headquartered at 67 rue Jules Lecesne, 76600 Le Havre. It is the reference French patient organization for Ehlers-Danlos Syndromes (EDS), a group of rare genetic connective-tissue disorders. The association is led by President Marie-Noëlle Gaveau with a volunteer Board of Directors and a Scientific Council, and its primary constituencies are EDS patients, their families, and the medical professionals who treat them. AFSED does not operate technology products; its core functions are patient support, medical information dissemination, therapeutic education, and medical research funding for all EDS subtypes.

The organization's service portfolio includes a quarterly journal (SED l'INFO), monthly email newsletters, a HONcode-certified website (afsed.com), regional meetings, an annual medical day in Paris, and the PrEduSED therapeutic patient education program for hypermobility-type EDS delivered at Clinique des Massues in Lyon. AFSED distributes emergency cards for vascular EDS patients, European patient passports, technical information sheets, and school guides. It co-funds medical research via annual calls for proposals (e.g., 126,620 euros pledged in 2018) and participates in research cohorts including RaDiCo-SED vasculaire. The association is formally integrated into France's national rare-disease infrastructure through Alliance Maladies Rares, FAVA-Multi, Maladies Rares Info Service, and three national reference centers (HEGP, Hôpital Raymond Poincaré Garches, Hôpital Necker-Enfants-Malades), as well as European Reference Networks VASCern and ReCOnnet and EURORDIS.

AFSED's revenue model is a mix of individual membership dues (30 euros/year, plus an optional 5 euros for the journal), individual and corporate donations, fundraising events including Téléthon solidarity walks and GROUPAMA partnerships, and pass-through research grants. Strategic financial partners include Fondation ROCHE, GROUPAMA, AFLAR, and AFM-Téléthon. Distribution is direct to members and through regional events and partner networks, with no commercial resellers. The association holds HONcode certification, an Orphanet listing, and a 2015 Label du droit des patients award recognizing its patient-centered VIVAMARE application.

toll holdings ltd firmographics

Firmographics
Name
toll holdings ltd
Legal name
AFSED - Association Française des Syndromes d'Ehlers-Danlos
Website
https://afsed.com
Company type
Private
Founded year
1997
Operating status
Operating
Headcount range
1–10 employees
Short description
AFSED is the French reference nonprofit patient association for Ehlers-Danlos Syndromes, founded 1997, supporting patients and families across France through information, therapeutic education, regional events, and medical research funding, in partnership with national reference centers and European Reference Networks.
Ownership category
akta.pro rank

Where toll holdings ltd is headquartered

Location

Headquarters

HQ city
Le Havre
HQ country
France
HQ region
Europe

Offices1 record

Markets served

toll holdings ltd business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Others, Personnel, Operations

Revenue model

  1. Membership fees: Annual membership fees of 30 euros per year providing access to all association activities, manifestations, and publications including the journal SED l'INFO (with additional 5 euros for the journal)
  2. Donations and fundraising: Donations from individuals and organizations; fundraising events including solidarity walks, charity sales, and participation in Téléthon
  3. Research project funding: Funding for medical research projects up to 60,000 euros per project through annual calls for proposals

Pricing tiers

ModelBillingPrice
SubscriptionAnnualStandard membership - 30 euros/year

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

toll holdings ltd product offering

Product offering

Core offering

AFSED is a French nonprofit patient association that supports individuals and families affected by Ehlers-Danlos Syndromes through membership services, therapeutic education programs (PrEduSED), annual medical days, a quarterly journal (SED l'INFO), emergency cards for vascular EDS patients, and a national helpline. The association funds medical research projects via annual calls for proposals and raises funds through memberships, donations, and solidarity events including Téléthon.

Differentiator

Problem solved

Functional benefit

Products and services

  • Annual Membership Annual membership open to patients, families, and supporters of the Association Française des Syndromes d'Ehlers-Danlos, providing access to all association activities, events, and publications for a fee of 30 euros per year (plus 5 euros for the quarterly journal).
  • PrEduSED Therapeutic Education Program Week-long therapeutic patient education (Education Thérapeutique du Patient) program at Clinique des Massues in Lyon, teaching hypermobility-type EDS patients to manage their disease, pain, and daily life through structured sessions held several times per year.
  • Emergency Cards for Vascular EDS Patients Urgency cards distributed to patients with vascular EDS, designed to inform emergency medical personnel of the patient's specific condition and care requirements to ensure appropriate emergency response.
  • Quarterly Journal SED l'INFO Quarterly journal providing medical articles, patient stories, association news, and research updates to AFSED members and subscribers.
  • Annual Research Funding Calls for Projects Annual calls for proposals funding medical research projects on Ehlers-Danlos Syndromes, with grants of up to 60,000 euros per project to support clinical and basic science research initiatives.
  • Donations and Fundraising Campaigns Donation and fundraising programs including solidarity walks (Randoraid de la Loire, GROUPAMA walks in Normandy and Pays de Loire), charity sales, and annual Téléthon participation to fund AFSED's operations and research.
  • Patient Helpline and Reference Center Navigation Phone helpline (0820 20 37 33) and reference center navigation services connecting EDS patients and families with specialized care providers such as HEGP, Necker-Enfants-Malades, and Hôpital Raymond Poincaré.
  • Annual Medical Day Conference Annual gathering in Paris bringing together patients, families, and medical professionals with expert presentations and workshops, typically held in November each year.

Quantifiable outcome

  • Reduced diagnostic delay through medical professional training and awareness programs
  • +1 more outcomes

Companies that use toll holdings ltd

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

toll holdings ltd technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

toll holdings ltd partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and major.

  • Alliance Maladies Rares (Rare Diseases Alliance)coreStrategic or Co-development PartnerAFSED is a member of the Alliance Maladies Rares, which brings together rare disease organizations in France. This affiliation provides national visibility, policy advocacy, and connection to the broader rare disease community.
  • EURORDIScoreStrategic or Co-development PartnerAFSED is affiliated with EURORDIS, the European organization bringing together rare disease associations across Europe. Enables participation in European policy initiatives and cross-border research.
  • European Reference Network (ERN) VASCerncoreStrategic or Co-development PartnerAFSED participates in VASCern, the European Reference Network for rare vascular diseases, connecting French reference centers with European centers of excellence for vascular EDS.
  • European Reference Network (ERN) ReCOnnetcoreStrategic or Co-development PartnerAFSED participates in ReCOnnet, the ERN for connective tissue and musculoskeletal disorders, supporting care for non-vascular EDS types.
  • FAVA-MulticoreStrategic or Co-development PartnerAFSED is part of FAVA-Multi, a filiere bringing together Reference Centers, competence centers and patient associations for rare vascular diseases, coordinating care pathways across France.
  • Maladies Rares Info ServicemajorStrategic or Co-development PartnerAFSED directs patients to Maladies Rares Info Service (tel: 01.56.53.81.36) for general rare disease information, providing a national resource for patients and families.
  • Centre de Référence des Maladies Vasculaires Rares (HEGP)coreStrategic or Co-development PartnerNational Reference Center for Rare Vascular Diseases at Hôpital Européen Georges Pompidou, Paris, directed by Pr Xavier Jeunemaitre. AFSED collaborates on research, patient support, and PNDS development for vascular EDS.
  • Centre de référence des syndromes d'Ehlers-Danlos non vasculaires (Garches)coreStrategic or Co-development PartnerReference center for non-vascular EDS at Hôpital Raymond Poincaré, Garches, under Dr Karelle Bénistan. Provides specialized care for classical and hypermobility EDS types.
  • Hôpital Necker-Enfants-Malades (Non-vascular EDS children)coreStrategic or Co-development PartnerPediatric reference center under Pr Valérie Cormier-Daire for children with non-vascular EDS, part of the national care network.
  • AFM-TéléthonmajorStrategic or Co-development PartnerAFSED co-organizes symposia with AFM-Téléthon, such as the Interface Muscle-tissu conjonctif symposium held in Lyon in March 2016.
  • OrphanetmajorStrategic or Co-development PartnerAFSED is listed on Orphanet, the European portal for rare disease information, providing visibility and referral pathways for patients seeking specialized care.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

toll holdings ltd competitors and assessment

Company assessment

Broad incumbents

  • NORD - National Organization for Rare Disorders: US umbrella organization for rare disease patient associations. Comparable in mission and structure to AFSED's relationship with Alliance Maladies Rares, providing advocacy, research funding, and patient resources at national scale.
  • EURORDIS - Rare Diseases Europe: European umbrella organization for rare disease patient associations, of which AFSED is a member. Sets pan-European policy, runs Rare Disease Day, and coordinates patient advocacy across member associations including AFSED.
  • AFM-Téléthon: Major French rare disease nonprofit running annual Téléthon fundraising and funding neuromuscular disease research. AFSED co-organizes symposia with AFM-Téléthon; comparable scale and French rare-disease nonprofit model.
  • Alliance Maladies Rares: French national alliance of rare disease patient associations, of which AFSED is a member. Provides policy advocacy, training, and shared services to member organizations including AFSED.

Others

  • Orphanet: European reference portal for rare diseases and orphan drugs, on which AFSED is listed. Acts as the directory and information backbone connecting EDS patient associations to clinicians and researchers worldwide.

Direct peers

  • The Ehlers-Danlos Society: Global patient organization for all EDS types, headquartered in the US, running international research, education, and the global EDS ECHO program. Directly comparable mission and scope to AFSED, but operating internationally rather than nationally.
  • Ehlers-Danlos Support UK: UK-based membership charity for EDS patients and families, providing helpline, information resources, and funding research. Closest national-association peer to AFSED in terms of patient support, fundraising, and member services model.

Regional players

  • Deutsche Ehlers-Danlos Initiative e.V. German national EDS patient association providing member support, information, and local events. Directly comparable role to AFSED in a neighboring country with similar healthcare system structure.

Market position

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

toll holdings ltd social profiles

Digital presence

toll holdings ltd financial estimates

Financial estimate

Revenue estimate

Valuation estimate

toll holdings ltd leadership team

Management profile

Number of profiles

Profiles1 record

toll holdings ltd funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

toll holdings ltd M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about toll holdings ltd

What does toll holdings ltd do?

AFSED is a French nonprofit patient association that supports individuals and families affected by Ehlers-Danlos Syndromes through membership services, therapeutic education programs (PrEduSED), annual medical days, a quarterly journal (SED l'INFO), emergency cards for vascular EDS patients, and a national helpline. The association funds medical research projects via annual calls for proposals and raises funds through memberships, donations, and solidarity events including Téléthon.

Is toll holdings ltd a public or private company?

toll holdings ltd is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was toll holdings ltd founded?

toll holdings ltd was founded in 1997. It employs 1 to 10 people.

Where is toll holdings ltd based?

toll holdings ltd is headquartered in Le Havre, France, in the Europe region.

How does toll holdings ltd make money?

Three revenue lines are on record. Membership fees are the primary driver. The others are donations and fundraising and research project funding.

Who are toll holdings ltd's main competitors?

Broad incumbents on record are NORD - National Organization for Rare Disorders, EURORDIS - Rare Diseases Europe, AFM-Téléthon and Alliance Maladies Rares. Orphanet is listed as an others. Direct peers are The Ehlers-Danlos Society and Ehlers-Danlos Support UK. Deutsche Ehlers-Danlos Initiative e.V. is listed as a regional player.

Does toll holdings ltd have an API?

No public API is recorded for toll holdings ltd.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales